Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBIT Margin (2016 - 2025)

OptimizeRx's EBIT Margin history spans 16 years, with the latest figure at 7.86% for Q3 2025.

  • For Q3 2025, EBIT Margin rose 4804.0% year-over-year to 7.86%; the TTM value through Sep 2025 reached 6.17%, up 3820.0%, while the annual FY2024 figure was 14.88%, 2204.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 7.86% at OptimizeRx, down from 10.92% in the prior quarter.
  • Across five years, EBIT Margin topped out at 11.25% in Q4 2024 and bottomed at 54.32% in Q1 2023.
  • The 5-year median for EBIT Margin is 19.93% (2024), against an average of 15.76%.
  • The largest annual shift saw EBIT Margin plummeted -3403bps in 2023 before it surged 4968bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 3.06% in 2021, then tumbled by -244bps to 4.4% in 2022, then crashed by -774bps to 38.43% in 2023, then surged by 129bps to 11.25% in 2024, then crashed by -30bps to 7.86% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's EBIT Margin are 7.86% (Q3 2025), 10.92% (Q2 2025), and 9.64% (Q1 2025).